Global Point-of-care Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 30692
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 93
  • list Pharmaceuticals and Healthcare

Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.

The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.

In 2020, the global Point-of-care Infectious Disease Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Point-of-care Infectious Disease Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-care Infectious Disease Diagnostics development in United States, Europe and China.

The key players covered in this study

Thermo Fisher Scientific

Alere

Calypte Biomedical

Chembio Diagnostic Systems

Meridian Bioscience

MedMira

Trinity Biotech

Sekisui Diagnostics

OraSure Technologies

Quidel

Market segment by Type, the product can be split into

HIV POC

Clostridium Difficile POC

HBV POC

Respiratory Syncytial Virus POC

HPV POC

Influenza/Flu POC

HCV POC

MRSA POC

TB and Drug-Resistant TB POC

Market segment by Application, split into

Hospitals

Clinics

Home

Assisted Living Healthcare Facilities

Laboratories

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Point-of-care Infectious Disease Diagnostics status, future forecast, growth opportunity, key market and key players.

To present the Point-of-care Infectious Disease Diagnostics development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Point-of-care Infectious Disease Diagnostics are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (2015-2026)

1.4.2 HIV POC

1.4.3 Clostridium Difficile POC

1.4.4 HBV POC

1.4.5 Respiratory Syncytial Virus POC

1.4.6 HPV POC

1.4.7 Influenza/Flu POC

1.4.8 HCV POC

1.4.9 MRSA POC

1.4.10 TB and Drug-Resistant TB POC

1.5 Market by Application

1.5.1 Global Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2026)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Home

1.5.5 Assisted Living Healthcare Facilities

1.5.6 Laboratories

1.5.7 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Point-of-care Infectious Disease Diagnostics Market Size

2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Regions

2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions (2015-2026)

2.2.2 Point-of-care Infectious Disease Diagnostics Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Point-of-care Infectious Disease Diagnostics Market Size by Manufacturers

3.1.1 Global Point-of-care Infectious Disease Diagnostics Revenue by Manufacturers (2015-2020)

3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)

3.2 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served

3.3 Key Players Point-of-care Infectious Disease Diagnostics Product/Solution/Service

3.4 Date of Enter into Point-of-care Infectious Disease Diagnostics Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)

4.2 Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

5 United States

5.1 United States Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

5.2 Point-of-care Infectious Disease Diagnostics Key Players in United States

5.3 United States Point-of-care Infectious Disease Diagnostics Market Size by Type

5.4 United States Point-of-care Infectious Disease Diagnostics Market Size by Application

6 Europe

6.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

6.2 Point-of-care Infectious Disease Diagnostics Key Players in Europe

6.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type

6.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application

7 China

7.1 China Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

7.2 Point-of-care Infectious Disease Diagnostics Key Players in China

7.3 China Point-of-care Infectious Disease Diagnostics Market Size by Type

7.4 China Point-of-care Infectious Disease Diagnostics Market Size by Application

8 Japan

8.1 Japan Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

8.2 Point-of-care Infectious Disease Diagnostics Key Players in Japan

8.3 Japan Point-of-care Infectious Disease Diagnostics Market Size by Type

8.4 Japan Point-of-care Infectious Disease Diagnostics Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

9.2 Point-of-care Infectious Disease Diagnostics Key Players in Southeast Asia

9.3 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Type

9.4 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Application

10 India

10.1 India Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

10.2 Point-of-care Infectious Disease Diagnostics Key Players in India

10.3 India Point-of-care Infectious Disease Diagnostics Market Size by Type

10.4 India Point-of-care Infectious Disease Diagnostics Market Size by Application

11 Central & South America

11.1 Central & South America Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)

11.2 Point-of-care Infectious Disease Diagnostics Key Players in Central & South America

11.3 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Type

11.4 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Application

12 International Players Profiles

12.1 Thermo Fisher Scientific

12.1.1 Thermo Fisher Scientific Company Details

12.1.2 Company Description and Business Overview

12.1.3 Point-of-care Infectious Disease Diagnostics Introduction

12.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.1.5 Thermo Fisher Scientific Recent Development

12.2 Alere

12.2.1 Alere Company Details

12.2.2 Company Description and Business Overview

12.2.3 Point-of-care Infectious Disease Diagnostics Introduction

12.2.4 Alere Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.2.5 Alere Recent Development

12.3 Calypte Biomedical

12.3.1 Calypte Biomedical Company Details

12.3.2 Company Description and Business Overview

12.3.3 Point-of-care Infectious Disease Diagnostics Introduction

12.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.3.5 Calypte Biomedical Recent Development

12.4 Chembio Diagnostic Systems

12.4.1 Chembio Diagnostic Systems Company Details

12.4.2 Company Description and Business Overview

12.4.3 Point-of-care Infectious Disease Diagnostics Introduction

12.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.4.5 Chembio Diagnostic Systems Recent Development

12.5 Meridian Bioscience

12.5.1 Meridian Bioscience Company Details

12.5.2 Company Description and Business Overview

12.5.3 Point-of-care Infectious Disease Diagnostics Introduction

12.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.5.5 Meridian Bioscience Recent Development

12.6 MedMira

12.6.1 MedMira Company Details

12.6.2 Company Description and Business Overview

12.6.3 Point-of-care Infectious Disease Diagnostics Introduction

12.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.6.5 MedMira Recent Development

12.7 Trinity Biotech

12.7.1 Trinity Biotech Company Details

12.7.2 Company Description and Business Overview

12.7.3 Point-of-care Infectious Disease Diagnostics Introduction

12.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.7.5 Trinity Biotech Recent Development

12.8 Sekisui Diagnostics

12.8.1 Sekisui Diagnostics Company Details

12.8.2 Company Description and Business Overview

12.8.3 Point-of-care Infectious Disease Diagnostics Introduction

12.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.8.5 Sekisui Diagnostics Recent Development

12.9 OraSure Technologies

12.9.1 OraSure Technologies Company Details

12.9.2 Company Description and Business Overview

12.9.3 Point-of-care Infectious Disease Diagnostics Introduction

12.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.9.5 OraSure Technologies Recent Development

12.10 Quidel

12.10.1 Quidel Company Details

12.10.2 Company Description and Business Overview

12.10.3 Point-of-care Infectious Disease Diagnostics Introduction

12.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)

12.10.5 Quidel Recent Development

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2025)

13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Point-of-care Infectious Disease Diagnostics Key Market Segments

Table Key Players Point-of-care Infectious Disease Diagnostics Covered

Table Global Point